Celea Therapeutics
PrivateLast Round
Seed
Jul 2, 2026
Est. Valuation
$302.5M
Total Funding Raised
$180M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Celea Therapeutics is a drug discovery company developing therapies for the treatment of respiratory conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Celea Therapeutics Comparables
Compare Celea Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Avalyn Pharma | 88% | |
| Endeavor Biomedicines | 80% | |
| Oorja Bio, Inc. | 79% |
Celea Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 2, 2026 | ||||
| VC Round | Apr 29, 2026 | ||||
| Spinoff | Aug 12, 2025 |
Celea Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Seed |
| PureTech Health | Seed, VC Round, Spinoff |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 2, 2026
$180M round with participation from Leaps by Bayer.
- Apr 29, 2026
PureTech Health participated in a VC Round.
Recent news
Latest coverage and updates
- receives_financingJul 2, 2026
celeatx received financing of $180M in financing on Jul 2nd '26.
Celea Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Celea Therapeutics's valuation, stock price, and market status.
Is Celea Therapeutics a public or private company?
Celea Therapeutics is a private company.
What is the current stock price of Celea Therapeutics?
Celea Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Celea Therapeutics worth (valuation)?
Celea Therapeutics's valuation is estimated at $302.5M based on funding round data.
Can I buy Celea Therapeutics stock?
Celea Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Celea Therapeutics's last funding round?
Celea Therapeutics's most recent funding round was Seed on July 2, 2026.
Who are the main investors in Celea Therapeutics?
Key investors in Celea Therapeutics include RA Capital Management, PureTech Health.
Will Celea Therapeutics IPO soon?
No public IPO plans have been announced for Celea Therapeutics.
How can I track Celea Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Celea Therapeutics's secondary market activity and sign up for updates.